Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Navitoclax/Venetoclax

Cytopenia and off label use

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Malfona F, et al. BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study. Haematologica 109: 988-993, No. 3, Mar 2024. Available from: URL: https://dx.doi.org/10.3324/haematol.2023.283684 Malfona F, et al. BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study. Haematologica 109: 988-993, No. 3, Mar 2024. Available from: URL: https://​dx.​doi.​org/​10.​3324/​haematol.​2023.​283684
Metadaten
Titel
Navitoclax/Venetoclax
Cytopenia and off label use
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55747-6

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Rituximab

Case report

Mitotane

Case report

Multiple drugs